Revance Therapeutics, Inc. (RVNC) financial statements (2021 and earlier)

Company profile

Business Address 7555 GATEWAY BLVD.
NEWARK, CA 94560
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:290176283186252171
Cash and cash equivalents1717328364202171
Short-term investments119103 12251 
Other undisclosed cash, cash equivalents, and short-term investments(0)(0)0(0)  
Restricted cash and investments    00
Receivables 270000
Prepaid expense  2111
Other current assets  0000
Other undisclosed current assets75(0)6  
Total current assets:297208285193254173
Noncurrent Assets
Operating lease, right-of-use asset27
Property, plant and equipment15149112019
Long-term investments and receivables    2 
Long-term investments    2 
Prepaid expense     0
Restricted cash and investments111100
Other noncurrent assets2311 0
Other undisclosed noncurrent assets     (0)
Total noncurrent assets:441810122220
TOTAL ASSETS:340226296204276192
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2723191699
Accounts payable887433
Accrued liabilities1915121264
Employee-related liabilities     2
Interest and dividends payable     0
Deferred revenue8
Debt3    3
Derivative instruments and hedges, liabilities3     
Contract with customer, liability9
Other liabilities     0
Other undisclosed current liabilities  233(2)
Total current liabilities:413221201210
Noncurrent Liabilities
Long-term debt and lease obligation26     
Operating lease, liability26
Liabilities, other than long-term debt48496655
Deferred revenue and credits3444
Deferred revenue48
Contract with customer, liability43
Deferred rent credit 3
Other liabilities   0  
Derivative instruments and hedges, liabilities 33212
Other undisclosed noncurrent liabilities   251
Total noncurrent liabilities:744968116
Total liabilities:1158127272316
Stockholders' equity
Stockholders' equity attributable to parent225146269177253176
Common stock000000
Additional paid in capital1,070830811599586435
Accumulated other comprehensive income (loss)0(0) (0)(0) 
Accumulated deficit(844)(685)(542)(422)(332)(259)
Total stockholders' equity:225146269177253176
TOTAL LIABILITIES AND EQUITY:340226296204276192

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues040000
Revenue, net   0
Cost of revenue
(Financial Services Costs)
  (0)(0)(0)(0)
Gross profit:04(0)(0)(0)0
Operating expenses(165)(146)(121)(89)(73)(52)
Other undisclosed operating income  0000
Operating loss:(164)(143)(120)(88)(72)(52)
Nonoperating income (expense)5311(0)(0)
Investment income, nonoperating641100
Other nonoperating expense(0)(1)(1)(1)(0)(0)
Interest and debt expense (0)(0)(1)(1)(19)
Other undisclosed loss from continuing operations before equity method investments, income taxes  (1)   
Loss from continuing operations before income taxes:(159)(139)(121)(89)(74)(71)
Income tax expense (3)    
Net loss:(159)(142)(121)(89)(74)(71)
Other undisclosed net income (loss) attributable to parent(0)(0) (1)08
Net loss available to common stockholders, diluted:(159)(143)(121)(89)(73)(63)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(159)(142)(121)(89)(74)(71)
Comprehensive loss:(159)(142)(121)(89)(74)(71)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)0(1)0 
Comprehensive loss, net of tax, attributable to parent:(159)(143)(121)(89)(74)(71)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: